What is Si-Bone Inc (SIBN) stock price today?

Si-Bone Inc (SIBN) currently trades at $12.39 per share. The stock has a market capitalization of $546.85M and a P/E ratio of —x.

Is SIBN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Si-Bone Inc has a Smart Value Score of 32/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Si-Bone Inc's revenue and earnings?

Si-Bone Inc has trailing twelve-month (TTM) revenue of $200.93M with profit margins of -9.41%. Earnings per share (EPS) is $-0.44.

Is SIBN stock overvalued or undervalued?

Based on our DCF model, Si-Bone Inc's intrinsic value is $32.74, representing a margin of safety of 54.25%. The stock currently trades at a P/E of —x.

SIBN

Si-Bone Inc

NASDAQ: SIBN · HEALTHCARE · MEDICAL DEVICES

$12.39

+3.86% today

Updated 2026-04-30

Market cap

$546.85M

P/E ratio

—

P/S ratio

2.72x

EPS (TTM)

$-0.44

Dividend yield

—

52W range

$12 – $22

Volume

0.6M

Market cap

$546.85M

P/E ratio

—

P/S ratio

2.72x

EPS (TTM)

$-0.44

Dividend yield

—

52W range

$12 – $22

Volume

0.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

7.3

Growth

B+

5.0

Quality

C+

2.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$25.50

+105.81%

12-Month target

—

Intrinsic (DCF)

$32.74

Margin of safety

+54.25%

3 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $440000.00 — positive

+ Revenue growth 15.00% QoQ

+ 54.25% below intrinsic value

Risks

- Thin margins at -9.41%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$106.41M	$138.89M	$167.18M	$200.93M	$200.93M
Net income	$-61.26M	$-43.34M	$-30.91M	$-18.91M	$-1.65M
EPS	—	—	—	—	$-0.44
Free cash flow	$-51.16M	$-26.51M	$-22.92M	$-9.09M	$440000.00
Profit margin	-57.57%	-31.20%	-18.49%	-9.41%	-9.41%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SIBN	$546.85M	32	7.3	2.0	6.7	5.0	+54.25%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Si-Bone Inc trades at $12.39. Our Smart Value Score of 32/100 indicates the stock is weak. TTM revenue stands at $200.93M. with profit margins at -9.41%. Our DCF model estimates intrinsic value at $32.74.

Frequently asked questions

What is Si-Bone Inc's stock price?

Si-Bone Inc (SIBN) trades at $12.39.

Is Si-Bone Inc overvalued?

Smart Value Score 32/100 (Grade F, Strong Sell). DCF value $32.74.

What is the price target of Si-Bone Inc (SIBN)?

The analyst target price is $25.50, representing +105.8% upside from the current price of $12.39.

What is the intrinsic value of Si-Bone Inc (SIBN)?

Based on our DCF model, intrinsic value is $32.74, a +54.3% margin of safety versus $12.39.

What is Si-Bone Inc's revenue?

TTM revenue is $200.93M.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio2.72x

ROE-11.00%

Beta0.77

50D MA$13.88

200D MA$16.12

Shares out0.04B

Float0.04B

Short ratio—

Avg volume0.6M

Performance

1 week-11.76%

1 month-8.30%

3 months-28.05%

YTD-39.50%

1 year—

3 years—

5 years—

Compare

SIBN vs LLY →SIBN vs JNJ →SIBN vs ABBV →Stock screener →